Science & Nature
- News & Views
- Published:
Sequencing
(2023)Cite this article
Subjects
Dual sequencing of the epigenome and genome could have broad implications in oncology.
Technologies for sequencing the epigenome are becoming a priority for precision medicine as epigenetic abnormalities are implicated in a growing number of diseases of aging1,2. To be clinically relevant, new sequencing methods should be able to identify epigenetic modifications while preserving the high accuracy of genome sequencing. A study in Nature Biotechnology by Füllgrabe et al.3 achieves this goal for the physiologically important epigenetic modifications 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC). Their six-base sequencing method accurately identifies these two modified bases along with the four unmodified DNA bases (A, G, C, T) in a single workflow. The approach has exciting implications for a wide array of applications including clinical sequencing, as the authors demonstrate in a test liquid biopsy from a patient with colon cancer.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Ehrlich, M. Epigenetics 14, 1141–1163 (2019).
Zhao, S. G. et al. Nat. Genet. 52, 778–789 (2020).
Füllgrabe, J. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-022-01652-0 (2023).
Nachun, D. et al. Aging Cell 20, e13366 (2021).
Carreras-Gallo, N. et al. Commun. Biol. 5, 455 (2022).
Kim, S. T. et al. Cancer Res. 79, 916 (2019).
Alexandrov, L. B. et al. Nature 578, 94–101 (2020).
Locke, W. J. et al. Front. Genet. 10, 1150 (2019).
Guler, G. D. et al. Nat. Commun. 11, 5270 (2020).
Tse, O. Y. O. et al. Proc. Natl Acad. Sci. USA 118, e2019768118 (2021).
Katsman, E. et al. Genome Biol. 23, 158 (2022).
Ethics declarations
Competing interests
A.M.C. serves on the scientific advisory board of Tempus and has a financial interest in the company.
Rights and permissions
About this article
Cite this article
George, J.M., Chinnaiyan, A.M. Speed reading the epigenome and genome.
Nat Biotechnol (2023). https://doi.org/10.1038/s41587-023-01757-0
Published:
DOI: https://doi.org/10.1038/s41587-023-01757-0
Read More
James M. George
